Federal funding is enabling biomedical engineer Jamie Spangler and her team to develop innovative treatments for autoimmune ...

A sponge-like implant in mice has helped guide a treatment that slowed or stopped a degenerative condition similar to ...

A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis (MS) in Finland between 2013 and 2022.

Multiple sclerosis (MS) is a chronic autoimmune disorder of the central nervous system (CNS) and a common cause for neurological disabilities in young adults. Although it is known that the peripheral ...

Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic ...

VANCOUVER, BC / ACCESS Newswire / February 19, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug ...

A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave University of Michigan researchers a first ...

Cataracts, a common eye condition characterized by clouding of the lens, often lead to blurred vision and, if left untreated, ...

Jamie Spangler oversees a lab of 33 scientists at Johns Hopkins who are developing new, targeted treatments that harness the power of the immune ...

Team GB athlete Lina Nielsen is starting treatment for multiple sclerosis – a decade after being diagnosed. She tells The i ...